Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EICKEMEYER - MEDICINTEKNIK FOR DYRLÆGER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   0.9% 0.9% 0.6% 0.5% 0.4% 0.6% 8.4% 7.9%   Credit score (0-100)   90 90 97 98 99 98 28 31   Credit rating   A A AA AA AAA AA BB BB   Credit limit (kDKK)   558.0 520.7 1,158.6 1,448.3 1,833.1 2,223.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,493 5,637 9,116 9,329 12,282 13,664 0.0 0.0   EBITDA   1,505 1,005 3,107 3,018 4,554 4,552 0.0 0.0   EBIT   1,500 959 3,008 2,777 4,289 4,234 0.0 0.0   Pre-tax profit (PTP)   1,445.9 856.4 3,041.3 2,875.9 4,199.6 4,127.9 0.0 0.0   Net earnings   1,124.6 663.3 2,363.8 2,224.1 3,276.6 3,223.6 0.0 0.0   Pre-tax profit without non-rec. items   1,446 856 3,041 2,876 4,200 4,128 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   12.9 407 4,423 5,555 5,537 5,597 0.0 0.0   Shareholders equity total   4,930 5,593 7,957 10,181 13,458 16,681 15,931 15,931   Interest-bearing liabilities   59.9 420 2,417 2,277 1,948 1,846 0.0 0.0   Balance sheet total (assets)   8,091 8,108 14,328 18,382 20,498 23,080 15,931 15,931   Net Debt   -2,263 234 312 -814 669 -1,173 -15,931 -15,931     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,493 5,637 9,116 9,329 12,282 13,664 0.0 0.0   Gross profit growth   14.3% 2.6% 61.7% 2.3% 31.7% 11.2% -100.0% 0.0%   Employees   7 8 9 11 14 17 0 0   Employee growth %   16.7% 14.3% 12.5% 22.2% 27.3% 21.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,091 8,108 14,328 18,382 20,498 23,080 15,931 15,931   Balance sheet change%   11.1% 0.2% 76.7% 28.3% 11.5% 12.6% -31.0% 0.0%   Added value   1,500.1 959.0 3,007.6 2,776.7 4,288.9 4,234.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -10 348 3,916 891 -283 -257 -5,597 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.3% 17.0% 33.0% 29.8% 34.9% 31.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.7% 11.9% 27.8% 18.2% 22.2% 19.4% 0.0% 0.0%   ROI %   29.4% 17.5% 38.0% 26.0% 30.9% 24.9% 0.0% 0.0%   ROE %   25.7% 12.6% 34.9% 24.5% 27.7% 21.4% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   60.9% 69.0% 55.5% 55.4% 65.7% 72.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -150.4% 23.3% 10.0% -27.0% 14.7% -25.8% 0.0% 0.0%   Gearing %   1.2% 7.5% 30.4% 22.4% 14.5% 11.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.4% 45.6% 5.7% 4.3% 5.5% 5.6% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   2.0 1.9 1.4 1.4 1.8 2.2 0.0 0.0   Current Ratio   2.5 3.1 2.3 2.1 2.9 3.8 0.0 0.0   Cash and cash equivalent   2,323.2 186.1 2,105.0 3,091.2 1,278.7 3,019.4 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,860.9 5,145.4 5,562.5 6,618.5 9,810.9 12,890.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   214 120 334 252 306 249 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   215 126 345 274 325 268 0 0   EBIT / employee   214 120 334 252 306 249 0 0   Net earnings / employee   161 83 263 202 234 190 0 0